Nuvectis Pharma, Inc.
NVCT • NASDAQ • Stock Fundamentals
Nuvectis Pharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ron Bentsur, with a market cap of $278.8M.
Market Cap$278.8M
Employees13.0
CEORon Bentsur
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Nuvectis Pharma, Inc. FAQ
Common questions about Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. (NVCT) has a market capitalization of $278.8M and trades on NASDAQ.
Nuvectis Pharma, Inc. has approximately 13 employees.